MedPath

BAXTER PHARMACEUTICAL SOLUTIONS LLC

🇺🇸United States
Ownership
Holding, Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

SFDA:3
PHILIPPINES:2

Drug Approvals

Cresemba

Approval Date
Jul 14, 2025
PHILIPPINES

Simponi

Approval Date
Jul 14, 2025
PHILIPPINES

Clinical Trials

No trials found

News

Simtra BioPharma Solutions Completes Major Facility Expansion in Germany to Meet Growing Injectable Therapeutics Demand

Simtra BioPharma Solutions has completed construction of a new 1,800 square meter production facility at its Halle, Germany campus, expanding total production area to nearly 12,000 square meters.

Simtra BioPharma Solutions and MilliporeSigma Form Strategic Alliance to Streamline ADC Manufacturing

Simtra BioPharma Solutions and MilliporeSigma have established a five-year strategic alliance to create a turnkey offering for antibody-drug conjugate manufacturing and bioconjugation services.

Simtra BioPharma Solutions Invests $14M to Expand ADC Manufacturing Capabilities

Simtra BioPharma Solutions announced a $14 million investment to expand clinical-scale conjugation and purification capabilities for antibody-drug conjugates at its Germany facility.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.